Activity of a newly identified serine protease in CNS demyelination
Open Access
- 1 June 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 125 (6) , 1283-1296
- https://doi.org/10.1093/brain/awf142
Abstract
We have identified a novel serine protease, myelencephalon‐specific protease (MSP), which is preferentially expressed in the adult CNS, and therein, is abundant in both neurones and oligodendroglia. To determine the potential activity of MSP in CNS demyelination, we examined its expression in multiple sclerosis lesions and in two animal models of multiple sclerosis: Theiler’s murine encephalomyelitis virus (TMEV) and myelin oligodendrocyte glycoprotein (MOG)‐induced experimental allergic encephalomyelitis (EAE) in marmosets. High levels of MSP were present within infiltrating mononuclear cells, including macrophages and T cells, which characteristically fill sites of demyelination, both in multiple sclerosis lesions and in animal models of this disease. The functional consequence of excess MSP on oligodendroglia was determined in vitro by evaluating the effects of recombinant MSP (r‐MSP) on oligodendrocyte survival and process number. Application of excess r‐MSP resulted in a dramatic loss of processes from differentiated oligodendrocytes, and a parallel decrease in process outgrowth from immature cells. Transfection of oligodendrocyte progenitors with an MSP–green fluorescent protein construct produced similar changes in oligodendrocyte process number. Importantly, r‐MSP did not affect oligodendrocyte survival or differentiation towards the sulphatide‐positive lineage. We further demonstrate that myelin basic protein, and to a lesser extent myelin oligodendrocyte glycoprotein, can serve as MSP substrates. These studies support the hypothesis that excess MSP, as is present in inflammatory CNS lesions, promotes demyelination.Keywords
This publication has 65 references indexed in Scilit:
- Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic windowBrain Research, 1995
- Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamineInflammation Research, 1995
- Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activatorNature, 1995
- In healthy primates, circulating autoreactive T cells mediate autoimmune disease.Journal of Clinical Investigation, 1994
- T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous systemEuropean Journal of Immunology, 1993
- Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic ProteinBiochemical and Biophysical Research Communications, 1993
- Autocrine inhibition of mitotic activity in cultured oligodendrocyte‐type‐2 astrocyte (O‐2A) precursor cellsGlia, 1992
- Multiple Sclerosis: Basic Concepts and HypothesisMayo Clinic Proceedings, 1989
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.The Journal of cell biology, 1980